Millennium Management’s Avadel Pharmaceuticals AVDL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-84,085
| Closed | -$1.81M | – | 5701 |
|
|
2025
Q4 | $1.81M | Sell |
84,085
-8,315
| -9% | -$161K | ﹤0.01% | 4028 |
|
|
2025
Q3 | $1.41M | Buy |
92,400
+74,400
| +413% | +$968K | ﹤0.01% | 4350 |
|
|
2025
Q2 | $159K | Sell |
18,000
-77,378
| -81% | -$680K | ﹤0.01% | 5434 |
|
|
2025
Q1 | $747K | Sell |
95,378
-1,116,626
| -92% | -$9.35M | ﹤0.01% | 4568 |
|
|
2024
Q4 | $12.7M | Buy |
1,212,004
+233,986
| +24% | +$2.84M | 0.01% | 1944 |
|
|
2024
Q3 | $12.8M | Buy |
978,018
+964,257
| +7,007% | +$14.7M | 0.01% | 1969 |
|
|
2024
Q2 | $193K | Sell |
13,761
-1,798,556
| -99% | -$29.3M | ﹤0.01% | 5150 |
|
|
2024
Q1 | $30.6M | Buy |
1,812,317
+1,607,783
| +786% | +$23.9M | 0.01% | 1178 |
|
|
2023
Q4 | $2.89M | Buy |
204,534
+149,808
| +274% | +$1.76M | ﹤0.01% | 3289 |
|
|
2023
Q3 | $564K | Buy |
+54,726
| New | +$733K | ﹤0.01% | 4587 |
|
|
2023
Q2 | – | Sell |
-288,910
| Closed | -$2.65M | – | 6099 |
|
|
2023
Q1 | $2.65M | Sell |
288,910
-320,426
| -53% | -$2.63M | ﹤0.01% | 3162 |
|
|
2022
Q4 | $4.36M | Buy |
+609,336
| New | +$4.27M | ﹤0.01% | 2931 |
|
|
2022
Q3 | – | Sell |
-212,590
| Closed | -$519K | – | 7049 |
|
|
2022
Q2 | $519K | Buy |
+212,590
| New | +$873K | ﹤0.01% | 4920 |
|
|
2022
Q1 | – | Sell |
-22,733
| Closed | -$156K | – | 6887 |
|
|
2021
Q4 | $184K | Buy |
+22,733
| New | +$208K | ﹤0.01% | 5968 |
|
|
2021
Q2 | – | Sell |
-32,378
| Closed | -$293K | – | 6509 |
|
|
2021
Q1 | $293K | Sell |
32,378
-282,973
| -90% | -$2.29M | ﹤0.01% | 5228 |
|
|
2020
Q4 | $2.11M | Sell |
315,351
-265,775
| -46% | -$1.66M | ﹤0.01% | 3195 |
|
|
2020
Q3 | $2.93K | Buy |
581,126
+154,245
| +36% | +$1.12M | ﹤0.01% | 2300 |
|
|
2020
Q2 | $3.45M | Sell |
426,881
-28,015
| -6% | -$247K | ﹤0.01% | 2100 |
|
|
2020
Q1 | $3.61M | Sell |
454,896
-173,931
| -28% | -$1.34M | 0.01% | 1590 |
|
|
2019
Q4 | $4.75M | Buy |
628,827
+509,939
| +429% | +$2.69M | 0.01% | 1981 |
|
|
2019
Q3 | $494K | Buy |
+118,888
| New | +$298K | ﹤0.01% | 3262 |
|
|
2019
Q2 | – | Sell |
-64,728
| Closed | -$93K | – | 4038 |
|
|
2019
Q1 | $93K | Sell |
64,728
-8,393
| -11% | -$19K | ﹤0.01% | 3852 |
|
|
2018
Q4 | $189K | Buy |
+73,121
| New | +$249K | ﹤0.01% | 3409 |
|
|
2018
Q3 | – | Sell |
-331,554
| Closed | -$2.03M | – | 3875 |
|
|
2018
Q2 | $2.03M | Sell |
331,554
-375,225
| -53% | -$2.63M | ﹤0.01% | 2388 |
|
|
2018
Q1 | $5.15M | Sell |
706,779
-137,621
| -16% | -$1.21M | 0.01% | 1793 |
|
|
2017
Q4 | $6.92M | Buy |
844,400
+178,200
| +27% | +$1.67M | 0.01% | 1562 |
|
|
2017
Q3 | $7M | Sell |
666,200
-100,173
| -13% | -$956K | 0.01% | 1474 |
|
|
2017
Q2 | $8.45M | Buy |
766,373
+618,954
| +420% | +$6.21M | 0.02% | 1149 |
|
|
2017
Q1 | $1.43M | Buy |
+147,419
| New | +$1.47M | ﹤0.01% | 2193 |
|
|
2016
Q4 | – | Sell |
-163,884
| Closed | -$2.03M | – | 3315 |
|
|
2016
Q3 | $2.03M | Sell |
163,884
-446,488
| -73% | -$5.83M | ﹤0.01% | 1928 |
|
|
2016
Q2 | $6.55M | Buy |
610,372
+141,201
| +30% | +$1.51M | 0.02% | 1095 |
|
|
2016
Q1 | $5.18M | Buy |
469,171
+214,923
| +85% | +$2.13M | 0.01% | 1235 |
|
|
2015
Q4 | $3.1M | Buy |
254,248
+107,470
| +73% | +$1.68M | 0.01% | 1657 |
|
|
2015
Q3 | $2.39M | Buy |
146,778
+108,460
| +283% | +$2.39M | ﹤0.01% | 1786 |
|
|
2015
Q2 | $812K | Sell |
38,318
-1,793,542
| -98% | -$32.2M | ﹤0.01% | 2381 |
|
|
2015
Q1 | $32.9M | Buy |
1,831,860
+736,721
| +67% | +$11.5M | 0.06% | 413 |
|
|
2014
Q4 | $18.8M | Buy |
1,095,139
+460,922
| +73% | +$6.58M | 0.04% | 639 |
|
|
2014
Q3 | $9.08M | Sell |
634,217
-153,618
| -19% | -$2.21M | 0.02% | 920 |
|
|
2014
Q2 | $11.8M | Sell |
787,835
-473,843
| -38% | -$5.72M | 0.03% | 741 |
|
|
2014
Q1 | $16.9M | Buy |
1,261,678
+1,080,910
| +598% | +$11.6M | 0.05% | 523 |
|
|
2013
Q4 | $1.46M | Sell |
180,768
-82,947
| -31% | -$585K | ﹤0.01% | 2050 |
|
|
2013
Q3 | $1.73M | Buy |
263,715
+203,225
| +336% | +$1.25M | 0.01% | 1781 |
|
|
2013
Q2 | $371K | Buy |
+60,490
| New | +$312K | ﹤0.01% | 2478 |
|
Other funds holding AVDL
Millennium Management's AVDL Position: Q1 2026 in Review
Millennium Management sold out of Avadel Pharmaceuticals (AVDL) in Q1 2026, closing a stake of 84,085 shares — an estimated $1.81M sold.
Millennium Management first reported a position in AVDL in Q2 2013 and held it in 43 quarters. The position peaked at $32.9M in Q1 2015. 2 funds tracked by Wall St. Rank hold AVDL as of Q1 2026.
- Millennium Management reported no remaining Avadel Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
- Millennium Management sold 84,085 Avadel Pharmaceuticals shares in Q1 2026, an estimated $1.81M.
- Millennium Management first reported a position in Avadel Pharmaceuticals in Q2 2013 and held it in 43 quarters.
- Millennium Management's Avadel Pharmaceuticals position peaked at $32.9M in Q1 2015.
- 2 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q1 2026.
Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.